Analgesic Efficacy, Safety and Tolerability of Two Paracetamol-Containing Solutions in Post-Surgical Hip Replacement Pain
- Conditions
- Interventions
- First Posted Date
- 2007-07-30
- Last Posted Date
- 2011-08-11
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 148
- Registration Number
- NCT00508495
- Locations
- 🇭🇺
Semmelweis Egyetem Ortopédiai Klinika, Budapest, Hungary
🇭🇺Réthy Pál Kórház-Rendelőintézet, Békéscsaba, Hungary
🇭🇺Esztergom Város Önkormányzat Vaszary Kolos Kórháza, Esztergom, Hungary
Pharmacokinetic and Safety Study of HYLENEX Recombinant-Augmented Subcutaneous Ceftriaxone Administration
- Conditions
- Interventions
- First Posted Date
- 2007-06-28
- Last Posted Date
- 2011-12-02
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 30
- Registration Number
- NCT00493220
Study of Subcutaneous Rehydration With Recombinant Human Hyaluronidase for Infants and Children
- Conditions
- Interventions
- First Posted Date
- 2007-05-22
- Last Posted Date
- 2011-12-01
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 52
- Registration Number
- NCT00477152
Analgesic Efficacy, Safety and Tolerability of Two Paracetamol-containing Solutions in Post-Surgical Dental Pain
- Conditions
- Interventions
- First Posted Date
- 2006-12-04
- Last Posted Date
- 2011-08-11
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 135
- Registration Number
- NCT00406679
- Locations
- 🇬🇧
University Dental Hospital of Manchester, Manchester, England, United Kingdom
🇬🇧University Dental Hospital NHS Trust Cardiff, Cardiff, Wales, United Kingdom
Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients
- Conditions
- First Posted Date
- 2006-11-09
- Last Posted Date
- 2017-05-08
- Lead Sponsor
- Baxter Healthcare Corporation
- Registration Number
- NCT00397358
- Locations
- 🇺🇸
Kaiser Santa Clara - Homestead, Santa Clara, California, United States
🇺🇸Nephrology Specialists, Michigan City, Indiana, United States
🇺🇸Dialysis Center of Lincoln, Lincoln, Nebraska, United States
Heart Failure and Peritoneal Ultrafiltration
- First Posted Date
- 2006-08-25
- Last Posted Date
- 2017-05-22
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 12
- Registration Number
- NCT00368641
A Crossover Study Assessing the Pharmacokinetics, Pharmacodynamics, and Safety of Recombinant Human Insulin
- Conditions
- First Posted Date
- 2006-08-01
- Last Posted Date
- 2007-03-13
- Lead Sponsor
- Baxter Healthcare Corporation
- Registration Number
- NCT00358553
- Locations
- 🇩🇪
Profil, Neuss, Germany
Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)
- Conditions
- Interventions
- First Posted Date
- 2006-02-06
- Last Posted Date
- 2017-04-05
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 70
- Registration Number
- NCT00287235
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
🇩🇰University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark
🇺🇸University of Alabama, Birmingham, Alabama, United States
A Subjective Evaluation of Inflow Pain Associated With the Use of an Experimental Solution for Peritoneal Dialysis
- Conditions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2006-11-22
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 20
- Registration Number
- NCT00214695
- Locations
- 🇸🇪
Huddinge Sjukhus, Njurmed kliniken K 56, Huddinge, Sweden
A Study to Evaluate the Efficacy and Safety of an Experimental Solution for Peritoneal Dialysis
- Conditions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2007-11-29
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 120
- Registration Number
- NCT00214721
- Locations
- 🇨🇦
St. Paul's Hospital, Vancouver, British Columbia, Canada